Amyvid may have cardiovascular use, too, study finds

07/16/2013 | (free registration)

Researchers presenting at a nuclear medicine meeting found that Amyvid, an amyloid-binding tracer used in brain imaging, can also detect cardiac amyloidosis, which can lead to cardiovascular disease. The research included three patients with mutated forms of transthyretin amyloid and five patients with light-chain amyloidosis. Findings point to "the potential for a clinical method of diagnosis in the quantification of myocardial amyloid load, which warrants further investigation," lead author Dr. Karen Wells said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC